We are delighted to share that Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, has published its first articles.
Working in conjunction with our publisher, Wiley, this journal strengthens Cochrane’s ability to meet our stakeholders’ needs and publish different types of evidence synthesis beyond systematic reviews. It also includes methods research evaluating how evidence syntheses is planned, produced and disseminated, and research articles on critical areas for evidence synthesis, such as, priority setting, consumer involvement, and research integrity.
With the launch Editorial New directions beyond the boundaries of evidence synthesis, Michael Brown (Editor, Cochrane Evidence Synthesis and Methods) and Ella Flemyng (Editorial Product Lead, Cochrane) discuss the scope and ethos of the journal, and how they hope the journal will contribute to the field.
Cochrane Evidence Synthesis and Methods’ first published paper is the rapid review on the effect of pharmacological interventions for the treatment of people with post-COVID-19, which is an exemplar for the types of rapid reviews we will feature. The authors, led by KM Saif-Ur-Rahman and Declan Devane (University in Galway, Ireland), worked closely with the World Health Organization, to ensure that the rapid review was relevant, timely and narrowly focused on therapeutic questions that directly apply to health care decisions.
Want to join the journal’s growing community?
- Sign up for content alerts so you never miss a new article
- Find out how to submit
- Register to be a peer reviewer (by creating an account in our Scholar 1 system)
Want to learn more about Cochrane Evidence Synthesis and Methods?
Michael Brown and Ella Flemyng recently discussed why Cochrane launched a new journal, what its aim is, and how people from across the community can get involved.
